Zimmer Biomet partnered with CBRE Group to develop orthopedic ASCs as part of a larger plan toward above-market growth, the devicemaker said May 29.
CBRE is the world's largest commercial real estate services and investment firm, and the partnership aims to expand patient access to Zimmer Biomet's orthopedic technology, according to a news release.
The partnership is part of Zimmer Biomet's larger three-year strategy to bring mid-single-digit revenue growth, raise adjusted earnings per share and grow free cash flow.